Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",Inverse variance weighted,12,0.92 [0.61-1.39],0.684854031572756
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,12,1.04 [0.94-1.15],0.457305301770651
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,12,1.12 [0.86-1.45],0.418388353367804
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,12,1.02 [0.93-1.13],0.667352158811645
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,12,0.39 [0.09-1.65],0.198700953394263
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,12,0.96 [0.78-1.19],0.717050520857261
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,12,0.80 [0.17-3.78],0.779640964242158
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,12,0.97 [0.85-1.12],0.711550417661414
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,12,0.89 [0.72-1.10],0.289272886214905
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,12,0.39 [0.20-0.73],0.003411157291864
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter II Neoplasms,Leiomyoma of uterus,Inverse variance weighted,12,0.23 [0.12-0.46],3.28524973993367e-05
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,12,0.98 [0.74-1.29],0.871707559350533
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,12,0.84 [0.59-1.18],0.308762593567458
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,12,0.73 [0.60-0.88],0.0011791816002031
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,12,1.02 [0.83-1.24],0.873166906871131
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",Inverse variance weighted,12,1.14 [0.82-1.58],0.435521130270631
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,12,0.75 [0.60-0.94],0.0117727592404622
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,12,1.05 [0.86-1.29],0.611413840206727
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,12,1.01 [0.84-1.23],0.886180799683794
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,12,1.02 [0.83-1.25],0.868075979371059
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,12,1.05 [0.88-1.26],0.56380424503508
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,12,1.03 [0.89-1.19],0.682293963628562
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,Inverse variance weighted,12,1.02 [0.81-1.29],0.882189106727706
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",Inverse variance weighted,12,1.08 [0.87-1.35],0.470040046799558
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,12,0.99 [0.82-1.20],0.935665245911784
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,12,1.20 [0.83-1.75],0.329092491324555
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,Depression,Inverse variance weighted,12,1.06 [0.96-1.17],0.248810520782867
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,Depression or dysthymia,Inverse variance weighted,12,1.09 [0.99-1.20],0.0931892217673024
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,Inverse variance weighted,12,0.74 [0.53-1.03],0.0775714687903738
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,12,0.93 [0.86-1.00],0.060261933602403
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",Inverse variance weighted,12,1.08 [0.93-1.26],0.326377776183723
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Other neurological diseases,Inverse variance weighted,12,1.05 [0.92-1.20],0.466757710860196
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,12,0.97 [0.70-1.36],0.878097934959384
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,Inverse variance weighted,12,0.99 [0.82-1.19],0.899421644520708
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,Inverse variance weighted,12,0.98 [0.81-1.18],0.825375865195573
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,12,0.91 [0.79-1.05],0.217107554456175
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,12,0.68 [0.53-0.87],0.0018835951678697
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,12,1.17 [0.94-1.45],0.158022476625379
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,12,1.02 [0.71-1.49],0.90082835570165
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Cardiomyopathy,Inverse variance weighted,12,0.69 [0.53-0.89],0.004019187272558
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,12,1.17 [0.92-1.48],0.191306917138463
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,12,0.89 [0.71-1.10],0.27001646853054
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,12,1.09 [0.89-1.33],0.396009462915679
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,12,0.91 [0.80-1.03],0.137483338386465
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,12,1.16 [0.87-1.55],0.320366270111348
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,12,0.84 [0.73-0.96],0.0129145161040012
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,12,0.83 [0.72-0.96],0.0110888273269756
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,12,0.40 [0.10-1.62],0.19865184339
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,12,0.79 [0.43-1.45],0.452493976607189
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,12,1.12 [0.94-1.33],0.194318073618066
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,12,1.01 [0.85-1.20],0.933284955379245
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,12,1.24 [0.96-1.60],0.104328487615365
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other arrhythmias,Inverse variance weighted,12,0.91 [0.81-1.03],0.13640715612175
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,12,0.65 [0.40-1.07],0.0933433374909437
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,12,1.51 [1.00-2.27],0.0478979160661779
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,12,0.75 [0.61-0.93],0.007375162265814
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,12,1.11 [0.90-1.38],0.329756515324949
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),Inverse variance weighted,12,1.19 [0.90-1.58],0.231521253338458
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Pulmonary embolism,Inverse variance weighted,12,1.04 [0.75-1.45],0.797474179554985
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,12,1.33 [0.64-2.75],0.441912257600748
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,12,1.03 [0.57-1.84],0.933951488650193
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,12,0.94 [0.80-1.11],0.480888342307809
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Transient ischemic attack,Inverse variance weighted,12,1.08 [0.93-1.26],0.289767606990623
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,Inverse variance weighted,12,1.11 [0.83-1.48],0.49567816758205
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,12,1.11 [0.92-1.35],0.279961627875454
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,12,2.78 [1.36-5.68],0.0049738276329252
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,12,3.46 [1.14-10.56],0.0289709662478462
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,12,0.89 [0.67-1.18],0.425338746220842
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,12,1.01 [0.91-1.12],0.875625492541538
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,12,1.03 [0.94-1.12],0.538050888511731
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,12,0.97 [0.89-1.06],0.489791081579761
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,12,1.01 [0.88-1.15],0.93328735022205
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,12,0.90 [0.74-1.09],0.289887328191973
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,12,0.84 [0.59-1.18],0.314195616425172
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,12,1.02 [0.90-1.16],0.72235950247758
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,Inverse variance weighted,12,1.33 [0.88-2.00],0.178831239739737
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,12,0.99 [0.88-1.10],0.795754673813976
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,12,0.74 [0.52-1.06],0.100549045609039
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,Inverse variance weighted,12,1.00 [0.85-1.19],0.960927011551239
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,12,0.99 [0.82-1.19],0.909509983651648
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,Inverse variance weighted,12,1.00 [0.81-1.24],0.983235591950094
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Hernia,Inverse variance weighted,12,1.01 [0.89-1.15],0.891898697872644
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,12,0.98 [0.87-1.10],0.677320171472863
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,12,0.99 [0.81-1.21],0.91411462400718
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Oesophagitis,Inverse variance weighted,12,1.43 [0.87-2.33],0.15949872256203
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,12,1.02 [0.93-1.13],0.633678546439545
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,Inverse variance weighted,12,1.20 [0.78-1.83],0.408324825508548
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,12,1.07 [0.89-1.27],0.475630797563457
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,12,0.98 [0.75-1.29],0.908131961723295
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,12,1.09 [0.92-1.28],0.315585913039185
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,12,0.97 [0.76-1.23],0.790455735607854
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,12,1.08 [0.99-1.17],0.0953207142696949
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,12,1.09 [0.90-1.31],0.365603622135555
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,12,0.89 [0.71-1.13],0.351718049558303
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,12,0.95 [0.83-1.09],0.469100085398658
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,12,0.95 [0.72-1.25],0.699396478604764
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,12,1.07 [0.98-1.18],0.143440464548814
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",Inverse variance weighted,12,1.07 [0.94-1.21],0.320958636425213
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,Inverse variance weighted,12,1.12 [0.96-1.31],0.141955130881669
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,12,1.10 [0.95-1.28],0.193955841013555
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,12,1.14 [0.91-1.42],0.252443226836791
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,Inverse variance weighted,12,1.19 [0.98-1.45],0.0847936124090345
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,12,1.09 [1.01-1.18],0.0335521211079822
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,12,1.11 [1.03-1.21],0.0079188245505521
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,12,0.99 [0.74-1.34],0.970227865561012
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,Inverse variance weighted,12,1.15 [1.03-1.28],0.0115153132718266
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,Inverse variance weighted,12,1.20 [1.04-1.39],0.0116280302825998
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,Inverse variance weighted,12,1.11 [0.97-1.28],0.134245228056412
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,12,1.12 [0.98-1.30],0.103872542487743
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,12,1.08 [0.82-1.43],0.578929237605468
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,12,1.09 [0.98-1.22],0.116313202372909
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,12,1.06 [0.90-1.25],0.50313111243455
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,12,1.15 [0.90-1.46],0.266608775716929
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,12,1.15 [1.04-1.28],0.0086871540959342
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,12,1.20 [1.02-1.41],0.0269449094048668
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,Inverse variance weighted,12,1.10 [0.97-1.24],0.125459359206544
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,Inverse variance weighted,12,1.21 [1.05-1.40],0.0107133968801805
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,12,1.26 [0.95-1.67],0.104148585800366
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,12,1.05 [0.85-1.29],0.641546645261484
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Cystitis,Inverse variance weighted,12,0.94 [0.81-1.09],0.423992400561531
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,12,0.62 [0.42-0.91],0.0148061875591685
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,12,1.14 [0.83-1.56],0.412926642309023
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,12,1.00 [0.90-1.11],0.973483767967715
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,12,1.19 [0.81-1.74],0.374624784104904
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Urethral stricture,Inverse variance weighted,12,0.82 [0.44-1.53],0.534529879403815
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,12,1.00 [0.89-1.13],0.979963471044635
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,12,0.98 [0.88-1.09],0.725166508475741
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,Inverse variance weighted,12,0.99 [0.87-1.12],0.854654258144387
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,12,1.21 [0.85-1.73],0.286148741005534
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,12,1.16 [0.90-1.48],0.245891392959449
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,12,1.34 [0.89-2.02],0.163764727232501
